Nebius Likely Hit Peak GPU Capacity (Rating Downgrade)

Nebius reported robust Q2 results, nearly doubling revenues and achieving breakeven adjusted EBITDA ahead of schedule, prompting management to raise ARR targets to approximately $1 billion. While shares surged 33% post-earnings, an analyst suggests the rally has fully priced in near-term growth, citing the company's apparent peak GPU capacity for 2025 and limited further ARR expansion beyond the new target, leading to a Hold recommendation given the current fair valuation of ~26x forward sales.

Analysis

Nebius (NBIS) has demonstrated strong operational momentum, reporting Q2 results that featured a near-doubling of revenues and the achievement of breakeven adjusted EBITDA ahead of internal schedules. This performance prompted management to confidently raise its Annual Recurring Revenue (ARR) guidance to approximately $1 billion. However, the market's reaction, a 33% surge in share price, has pushed the company's valuation to a demanding level of approximately 26 times forward sales. This valuation is seen as fully reflecting the company's near-term growth prospects. A key concern tempering the outlook is the assessment that Nebius has reached its peak GPU capacity for 2025, presenting a significant bottleneck and no clear path for meaningful ARR expansion beyond the new $1 billion target within the current year.

Key Decisions for Investors

• Given the 33% post-earnings rally and a valuation of ~26x forward sales, investors considering initiating a new position should exercise caution as the near-term positive outlook appears to be fully priced into the stock.
• Current shareholders may find it prudent to hold their positions based on strong fundamental performance, but should closely monitor any company announcements regarding GPU procurement or data center expansion, as this is the primary identified constraint to future growth.
• Investors should scrutinize future management commentary for a clear strategy on how Nebius plans to expand its revenue base beyond the current $1 billion ARR target, as the path for continued hyper-growth is currently unclear.